Envestnet Asset Management Inc Novo Nordisk A S Transaction History

Envestnet Asset Management Inc

$263 Billion
Q1 2024

A detailed history of Envestnet Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Envestnet Asset Management Inc holds 4,195,245 shares of NVO stock, worth $568 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

4,195,245

Previous 4,213,978 0.44%

Holding current value

$568 Million

Previous $436 Million 23.57%

% of portfolio

0.2%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $1.91 Million - $2.55 Million	-18,733 Reduced 0.44%	4,195,245 $539 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $29.7 Million - $35.7 Million	-338,503 Reduced 7.44%	4,213,978 $436 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $253 Million - $555 Million	2,779,866 Added 156.82%	4,552,481 $414 Million
Q2 2023 Aug 04, 2023	SELL	$155.98 - $172.65 $552 Million - $611 Million	-3,536,251 Reduced 66.61%	1,772,615 $287 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $468 Million - $563 Million	3,537,248 Added 199.66%	5,308,866 $845 Million

Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $3.37 Million - $4.45 Million	-32,848 Reduced 1.82%	1,771,618 $240 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $301,561 - $370,083	-3,165 Reduced 0.18%	1,804,466 $180 Million
Q2 2022 Aug 03, 2022	BUY	$103.24 - $121.81 $21.1 Million - $24.8 Million	203,998 Added 12.72%	1,807,631 $201 Million
Q1 2022 May 04, 2022	BUY	$93.1 - $112.54 $17.3 Million - $20.9 Million	186,122 Added 13.13%	1,603,633 $178 Million
Q4 2021 Feb 04, 2022	BUY	$95.88 - $117.08 $7.24 Million - $8.84 Million	75,538 Added 5.63%	1,417,511 $159 Million
Q3 2021 Oct 07, 2021	BUY	$84.42 - $106.62 $3.56 Million - $4.49 Million	42,140 Added 3.24%	1,341,973 $129 Million
Q2 2021 Aug 04, 2021	BUY	$67.66 - $84.76 $3.44 Million - $4.31 Million	50,877 Added 4.07%	1,299,833 $109 Million
Q1 2021 May 04, 2021	BUY	$67.06 - $75.82 $5.15 Million - $5.82 Million	76,766 Added 6.55%	1,248,956 $84.2 Million
Q4 2020 Feb 02, 2021	BUY	$63.89 - $73.8 $976,111 - $1.13 Million	15,278 Added 1.32%	1,172,190 $81.9 Million
Q3 2020 Oct 09, 2020	SELL	$63.69 - $70.22 $549,326 - $605,647	-8,625 Reduced 0.74%	1,156,912 $80.3 Million
Q2 2020 Jul 08, 2020	BUY	$58.54 - $67.94 $2.27 Million - $2.63 Million	38,756 Added 3.44%	1,165,537 $76.3 Million
Q1 2020 Apr 23, 2020	BUY	$49.46 - $64.78 $3.72 Million - $4.87 Million	75,115 Added 7.14%	1,126,781 $67.8 Million
Q4 2019 Feb 11, 2020	BUY	$49.86 - $58.26 $1.33 Million - $1.56 Million	26,722 Added 2.61%	1,051,666 $60.9 Million
Q3 2019 Oct 17, 2019	BUY	$47.54 - $53.43 $1.88 Million - $2.12 Million	39,610 Added 4.02%	1,024,944 $53 Million
Q2 2019 Aug 02, 2019	BUY	$46.79 - $52.47 $1.07 Million - $1.2 Million	22,950 Added 2.38%	985,334 $50.3 Million
Q1 2019 May 10, 2019	SELL	$46.36 - $52.63 $1.39 Million - $1.57 Million	-29,891 Reduced 3.01%	962,384 $50.3 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $16.9 Million - $19.3 Million	407,841 Added 69.78%	992,275 $45.7 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $1.91 Million - $2.1 Million	-40,915 Reduced 6.54%	584,434 $27.6 Million
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $25 Million - $28.5 Million	565,395 Added 943.05%	625,349 $28.8 Million
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $52.7 Million - $63.2 Million	-1,086,601 Reduced 94.77%	59,954 $2.94 Million
Q4 2017 Feb 20, 2018	BUY	$47.53 - $53.73 $393,833 - $445,206	8,286 Added 0.73%	1,146,555 $61.5 Million
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $1.22 Million - $1.46 Million	-29,692 Reduced 2.54%	1,138,269 $54.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,167,961	1,167,961 $50.1 Million

Others Institutions Holding NVO

# of Institutions

1,851

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $305B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Novo Nordisk A S Transaction History